Am J Health Syst Pharm. 2010;67(14):1157-1164. Vernakalant hydrochloride injection, an antiarrhythmic agent under review by the Food and Drug Administration (FDA) for the rapid conversion of AF to ...
Fact checked byProfessional Communications, Inc. Antiarrhythmic drugs act on the electrical conduction system of the heart. The most common use of these drugs is as part of a rhythm control strategy ...
Hosted on MSN
Antiarrhythmic drugs for atrial fibrillation
Antiarrhythmic drugs can cause new, potentially deadly heart arrhythmias. Amiodarone is effective but can cause serious side effects and requires careful monitoring. Multaq cannot be used in people ...
Findings reported in The American Journal of Pathology suggest dofetilide may counteract pathological changes in potassium channels associated with pulmonary arterial hypertension in humans and rats ...
Tiny pores in heart cells generate electrical signals to initiate each heart beat. Structural studies of these channels provide details on their functions, and also on their malfunction due to ...
Active ingredient: Dronedarone 400 mg; tabs. Indication: To reduce risk of cardiovascular hospitalization in patients with paroxysmal or persistent atrial fibrillation (AF) or atrial flutter (AFL) ...
Intravenous vernakalant, a novel, relatively atrial-selective antiarrhythmic agent, appears to offer a safe and effective means of converting recent-onset AF to normal sinus rhythm.
High blood pressure in the lungs, known as pulmonary arterial hypertension (PAH), is a potentially fatal disease caused by obstruction of blood flow in the lungs. A new study in The American Journal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results